A team of Georgia Tech engineers developed a custom 3-D printed splint to support a newborn's airway, like an internal cast that dissolves as the trachea strengthens. Children’s Healthcare of Atlanta is one of only five hospitals in the nation offering this surgery.
Once called Nantucket fever, the tick-borne illness babesios is spreading from the Northeast into the Midwest. A clinical trial starts this month to see if an anti- malaria drug can treat the disease.
People with post-traumatic stress disorder (PTSD) may soon have a new treatment option: MDMA, the chemical found in ecstasy. In August, the Food and Drug Administration plans to decide whether MDMA-assisted therapy for PTSD will be approved for market based on years of research. But serious allegations of research misconduct may derail the approval timeline.
NPR science reporter Will Stone talks to host Emily Kwong about the clinical trials on MDMA-assisted therapy research and a recent report questioning the validity of the results.
With IT systems down, staff at Ascension have to use manual processes they left behind some 20 years ago. It's the latest in a string of attacks on health care systems that house private patient data.
The state covers basic services for vulnerable residents, including things like air purifiers for kids with asthma. But nonprofits offering the services struggle to work within the health care system.
America is a land of contradictions; while we're known as a nation that loves to eat, we also live within a culture that has long valued thinness as the utmost beauty standard.
Over the last several years the body positivity movement has pushed back on that notion. But then came a new class of weight-loss drugs.
New York Magazine contributing writer Samhita Mukhopadhyay grapples with the possible future of a movement like this in her recent article, So Was Body Positivity All A Big Lie?
She joins All Things Considered host Juana Summers to discuss the ever-evolving conversation on health, size, and whose business that is in the first place.
For sponsor-free episodes of Consider This, sign up for Consider This+ via Apple Podcasts or at plus.npr.org.
When Thorsten Siess was in graduate school, he came up with the idea for a heart device that's now been used in hundreds of thousands of patients around the world.
Clinical trials of MDMA have been promising, but concerns have emerged about the quality of the research. A June hearing scheduled by the Food and Drug Administration is likely to address them.
Richard Slayman died almost two months after the historic procedure, the Boston hospital where he had the transplant said Saturday. At 62, he had the transplant to treat his end-stage kidney disease.
